Characterization of tertiary lymphoid structures and its association with response to immune checkpoint inhibitors in triple negative breast cancer using spatial transcriptomics

被引：1
|
作者：
Wang, Xiaoxiao
Venet, David
Lifrange, Frederic
Larsimont, Denis
Rediti, Mattia
Stenbeck, Linnea
Dupont, Floriane
Rouas, Ghizlane
Garcia, Andrea Joaquin
Gacquer, David
Craciun, Ligia
Buisseret, Laurence
Bhalla, Nayanika
Masarapu, Yuvarani
Thrane, Kim
Villacampa, Eva Gracia
Franzen, Lovisa
Saarenpaa, Sami
Kvastad, Linda
Lundeberg, Joakim
Rothe, Francoise
Sotiriou, Christos
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO3-25-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO3-25-07
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Heterogeneity of tertiary lymphoid structures predicts the response to neoadjuvant therapy and immune microenvironment characteristics in triple-negative breast cancer
    Wang, Qing
    Yu, Yushuai
    Wang, Chenxi
    Jiang, Zirong
    Li, Jialu
    Li, Xiaofen
    Huang, Xiewei
    Song, Ying
    Li, Zhenhui
    Tang, Shicong
    Song, Chuangui
    BRITISH JOURNAL OF CANCER, 2025, 132 (03) : 295 - 310
  • [2] Prognostic Impact of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer
    Iqbal, Jabed
    Ahmed, Syed
    Yeong, Joe
    Goh, Henry
    Tham, Jing Yang
    Koh, Valerie
    LABORATORY INVESTIGATION, 2024, 104 (03) : S176 - S177
  • [3] Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer
    Solinas, Cinzia
    Garaud, Soizic
    De Silva, Pushpamali
    Boisson, Anais
    Van den Eynden, Gert
    de Wind, Alexandre
    Risso, Paolo
    Vitoria, Joel Rodrigues
    Richard, Francois
    Migliori, Edoardo
    Noel, Gregory
    Duvillier, Hugues
    Craciun, Ligia
    Veys, Isabelle
    Awada, Ahmad
    Detours, Vincent
    Larsimont, Denis
    Piccart-Gebhart, Martine
    Willard-Gallo, Karen
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [4] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer: The Search for the Optimal Biomarker
    Qureshi, Sadaf
    Chan, Nancy
    George, Mridula
    Ganesan, Shridar
    Toppmeyer, Deborah
    Omene, Coral
    BIOMARKER INSIGHTS, 2022, 17
  • [5] Identification of circulating and spatial dynamics of immune cells response to to immune checkpoint inhibitors in triple-negative breast cancer at single-cell resolution
    Seo, Eun Seop
    Jung, Hae Hyun
    Kim, Kibyung
    Park, Kyunghee
    Ko, Eun Young
    Chae, Byung Joo
    Lee, Jeong Eon
    Cho, Eun Yoon
    Kim, Ji-Yeon
    Park, Woong-Yang
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    Isaacs, James
    Anders, Carey
    McArthur, Heather
    Force, Jeremy
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (05)
  • [7] Biomarkers of Immune Checkpoint Blockade Response in Triple-Negative Breast Cancer
    James Isaacs
    Carey Anders
    Heather McArthur
    Jeremy Force
    Current Treatment Options in Oncology, 2021, 22
  • [8] Our experience with immune checkpoint inhibitors in triple-negative breast cancer patients
    Nishio, Minako
    Kojitani, Yoshiki
    Kitashiro, Saya
    Ishiduka, Yasunobu
    Otsuka, Tomoyuki
    Nishida, Naohiro
    Fujisawa, Fumie
    Sugimoto, Naotoshi
    Yagi, Toshinari
    Souma, Ai
    Kanaoka, Haruka
    Oyamayama, Yuri
    Taniguchi, Azusa
    Nakajima, Satomi
    Seto, Yukiko
    Kusama, Hiroki
    Watanabe, Noriyuki
    Matsui, Saki
    Nakayama, Takahiro
    Kudou, Toshihiro
    ANNALS OF ONCOLOGY, 2023, 34 : S1465 - S1465
  • [9] Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects
    Thomas, Remy
    Al-Khadairi, Ghaneya
    Decock, Julie
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [10] The Evolving Role of Immune Checkpoint Inhibitors in the Treatment of Triple-Negative Breast Cancer
    Steiner, Meghan
    Tan, Antoinette R.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (05) : 305 - 315
12345